Where does Elucid Bioimaging Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Elucid Bioimaging Inc. ranks #8,019 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Elucid Bioimaging Inc. hold?

Elucid Bioimaging Inc. holds 40 US utility patents granted between 2016 and 2025, spanning 9 technology areas.

What is Elucid Bioimaging Inc.'s Innovation Score?

Elucid Bioimaging Inc. has an Innovation Score of 57.2 out of 100 (top 5% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Elucid Bioimaging Inc.'s patent grant rate increasing or decreasing?

Elucid Bioimaging Inc.'s recent grant velocity is +1700% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Elucid Bioimaging Inc.'s patents?

Elucid Bioimaging Inc.'s patents average 23.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Elucid Bioimaging Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Elucid Bioimaging Inc.

Q: What technology areas does Elucid Bioimaging Inc. focus on?

Elucid Bioimaging Inc.'s top technology area is G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data) with 34 patents, ranking #139 of 3,149 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

USPTO PatentsView assignee record - 40 granted patents across 9 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Elucid ranks #8,019 of 49,997 tracked US assignees by granted-patent volume, with 40 patents across 9 technology areas.

#8,019
of 49,997 US assignees by volume: Top 5%
by Innovation Score (57.2/100): 23.0
avg claims per patent: +1700%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8019 · US Corporation #8,019 · 40 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 40 grants
UPPER-Q #8,019/49,997
PHOTO-FINISH Dialogic
CPC-NARROW G16H · 9 areas
INNOV-PAR 57.2/100
CLAIMS-DENSE 23.0 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +1700% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Dialogic Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Elucid’s 57.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.8 pts (22%) Velocity 20.0 pts (35%) Breadth 10.6 pts (19%) Claim depth 13.8 pts (24%)

Qualcomm Incorporated · highest

85
Bayer Cropscience… · near

57
Elucid Bioimaging · this assignee

57
InCube Labs · near

57
Sakuu · near

57
Hoffman Enclosures · near

57
3D Lighting… · lowest

7

What this shows Elucid's Innovation Score is 57.2/100 (top 5% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Elucid?

Each dot is one of Elucid’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Elucid’s own 23.0 claims/patent is ABOVE the 16.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Elucid vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Elucid's grants concentrate

Elucid Bioimaging Inc. is a focused PatentsView assignee: 9 CPC subclasses with 85% of grants classified under G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data). Peak complete grant year is 2024 (20 grants) versus a trough of 1 in 2016. By volume, Elucid sits between Dialogic Corporation and EagleBurgmann Germany GmbH & Co. KG.

Elucid's three-year grant acceleration

Elucid Bioimaging Inc. shows 29 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Dialogic

40
Dongguan Shichang…

40
E &J Gallo Winery

40
Echostar Internat…

40
Endoevolution

40
ERP Power

40
Eagle View

40
Eagleburgmann Ger…

40
Elucid Bioimaging ◀

40

What this shows Elucid holds 40 patents at rank #8,016, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Elucid

By rank, the assignees closest to #8,016 in granted patent volume.

Leaders in G16H (Healthcare Informatics)

Other assignees with the most granted patents in Elucid's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Elucid, neither rank-band nor same-CPC leaders (those blocks stay above). In G16H (Healthcare Informatics), Elucid ranks #139 of 3,149 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (57 here).

Sakuu Corporation 57 InCube Labs, LLC 57 Bayer Cropscience Aktiengesellschaft 57 Hoffman Enclosures Inc. 57

Elucid's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

57 Top 5% higher than 95% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Elucid Bioimaging Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	2.5%
2019	1	2.5%
2020	2	5.0%
2021	5	12.5%
2022	2	5.0%
2023	7	17.5%
2024	20	50.0%
2025partial year	2	5.0%

Which technologies does Elucid Bioimaging Inc. patent most?

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 34

G06T - Image Data Processing OR Generation, IN General 31

A61B - DIAGNOSIS; SURGERY; Identification 28

G06V - Image OR Video Recognition OR Understanding 21

G06F - Electric Digital Data Processing 21

G06N - Computing Arrangements Based ON Specific Computational Models 16

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 7

G16C - Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science 2

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Elucid Bioimaging Inc.'s patent record in context - here's where to go next.

Elucid Bioimaging Inc.'s lead technology class is G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data), 85% of its portfolio - see every assignee active in that class. Explore G16H
Ranked #8,019 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Elucid Bioimaging Inc. against Dialogic Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 57.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.